CEL SCI CORP

CVMSEC EDGAR

Biological Products, (No Diagnostic Substances)(CO)CIK: 725363

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenues	—	—	—	—	—
Research and Development Expense	$18.2M	$22.5M	$25.4M	$23.1M	$17.8M
Operating Expenses	$26.4M	$31.5M	$36.1M	$36.2M	$29.5M
Operating Income (Loss)	-$26.4M	-$31.5M	-$36.1M	-$36.2M	-$29.0M
Interest Expense	$746.0K	$675.4K	$1.1M	—	—
Nonoperating Income (Expense)	—	—	—	—	—
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	—	—	—	—	—
Net Income (Loss) Attributable to Parent

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$27.0M	$30.5M	$50.5M	$75.9M	$40.5M
Assets, Current	$6.1M	$6.9M	$25.4M	$45.3M	$17.7M
Cash and Cash Equivalents, at Carrying Value	—	—	—	$36.1M	$8.4M
Accounts Receivable, after Allowance for Credit Loss, Current	—	—	—	$54.9K	$54.9K
Inventory, Net	—	$2.2M	$2.0M	$2.0M	$820.1K
Liabilities	$14.1M	$17.3M	$18.4M	$19.3M	$20.8M
Liabilities, Current	$4.6M	$5.6M	$4.7M	$3.9M	$4.3M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$18.8M	-$22.8M	-$18.2M	-$18.8M	-$15.3M
Net Cash Provided by (Used in) Investing Activities	-$108.1K	-$372.3K	$5.5M	-$15.2M	-$2.7M
Net Cash Provided by (Used in) Financing Activities	$19.5M	$4.7M	-$638.4K	$54.5M	$25.0M
Payments to Acquire Property, Plant, and Equipment	$94.9K	$361.9K	$637.9K	$9.0M	$2.7M

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)